Trials / NCT04252534
Management of Retinitis Pigmentosa Via Electromagnetic Stimulation and Platelet Rich Plasma
Completed N/A Drug / neuroprotection
- Sponsor
- Ankara Universitesi Teknokent
- Treatment
- PRP combined Magnovision; PRP
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to 60 Years
- Enrollment
- 60 participants
- Started
- 2017-01-01
- Main results expected
- 2019-12-30
- Results posted
- Not yet
- Record last updated
- 2020-02-05
What the study is testing
The aim of this study is to investigate whether natural progression rate can be slowed down with subtenon PRP or PRP application combined with rEMS in retinitis pigmentosa cases.
Where it runs
No sites listed yet.